Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany

BACKGROUND: Medical studies have shown that switching to exemestane after 2-3 years of adjuvant treatment with tamoxifen is effective when looking at overall survival. No cost effectiveness study of exemestane has been conducted in the German health care context. PATIENTS AND METHODS: To assess the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Braun, Sebastian, Mittendorf, Thomas, Menschik, Thomas, Greiner, Wolfgang, von Schulenburg, Johann-Matthias
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger GmbH 2009
Témata:
Original Article · Originalarbeit
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2942002/
https://ncbi.nlm.nih.gov/pubmed/20877674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000255840
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky